5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Our products
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Pharmaceutical companies must embrace pioneering new product launch software if they really want to optimise launch readiness to capitalise on renewed innovation and R&D productivity.
We take a look at the Top 6 Pharma Trends for 2019: From slowing sales growth, biosimilars getting serious, growing pressure on US pricing, more Brexit uncertainty, value focused R&D to the need to address the industry’s ‘me-too’ deficit.
The right tender management tools will help pharmaceutical and biotechnology companies overcome the market access challenges of a growing but complex tenders sector.
The right digital management tools will help pharmaceutical companies overcome the market access challenges of a growing but complex tenders sector.
6 of our key pharma trends that will shape the industry are illustrated on our pharma trends for 2018 infographic.
Value, innovation, inter-connectivity, personalisation, and the disruptive impact of digital tools and online retail: these are key pharma trends for 2018.
Effective and proactive tender management is critical to capitalising on new growth opportunities for pharmaceuticals and vaccines worldwide.
A smart business tool can save you time to optimise efficiency and market access in a pharma sector swamped with data, communications and multiple inputs.
Close attention to launch timelines and status will help save you from stumbling at the final hurdle to successful pharma market entry.
Making the most of pharma launch planning includes ensuring that launch team members are focused on strategic objectives, not data collection and processing.
A launch readiness framework is a must to handle pharma market access challenges. You need the tools to ensure a living framework is embedded enterprise wide.
Damaging constraints on patient access to medicines come from many quarters. Pharma companies must ensure that poorly co-ordinated and executed drug launches are not to blame.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.